U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07456449) titled 'Collagen Peptides and Cellular Aging' on Feb. 23.
Brief Summary: The goal of this clinical trial is to learn if daily collagen peptide supplementation can stabilize or lengthen telomeres and improve related markers of cellular aging in adults aged 50-70 years with overweight and low-to-moderate physical activity (healthy volunteers without major chronic disease).
Main questions it aims to answer are:
Does six months of collagen peptides stabilize or extend telomere length and increase telomerase activity compared with placebo? Are any telomere-related changes associated with lower inflammation, healthier body composition, and bett...